Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China

BMC Endocrine Disorders

Volumn 11, Issue , 2011, Pages

  Thompson, Angela M ^a   Zhang, Yonghong ^b   Tong, Weijun ^b   Xu, Tan ^b   Chen, Jing ^a,c   Zhao, Li ^d   Kelly, Tanika N ^a   Chen, Chung Shiuan ^a   Bazzano, Lydia A ^a,c   He, Jiang ^a,c  

^a TULANE UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Tongliao Center for Disease Prevention and Control   (China)

Author keywords

C reactive protein; Diabetes; E selectin; Endothelial dysfunction; Inflammation; Intercellular adhesion molecule 1; Metabolic syndrome

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; TRIACYLGLYCEROL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHINA; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FAMILY HISTORY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SEX DIFFERENCE; SMOKING; WAIST CIRCUMFERENCE;

EID: 80053632380     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-11-16     Document Type: Article

References (37)

1. Ilanne-Parikka P, Eriksson JG, Lindström J, Hämäläinen H, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J. Prevalence of the Metabolic Syndrome and Its Components. Diabetes Care 2004, 27(9):2135-2140. 10.2337/diacare.27.9.2135, 15333474.
2. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004, 173(2):307-312.
3. Reynolds K, He J. Epidemiology of the metabolic syndrome. Am J Med Sci 2005, 330(6):273-279. 10.1097/00000441-200512000-00004, 16355011.
4. Yang W, Reynolds K, Gu D, Chen J, He J. A Comparison of Two Proposed Definitions for Metabolic Syndrome in the Chinese Adult Population. Am J Med Sci 2007, 334(3):184-189. 10.1097/MAJ.0b013e3180a6ed66, 17873532.
5. Tong PC, Kong AP, So W, Yang X, Ho C, Ma RC, Ozaki R, Chow C, Lam CW, Chan JCN, Cockram CS. The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes. Diabetes Care 2007, 30(5):1206-1211. 10.2337/dc06-1484, 17259472.
6. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Lin L, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Shan G, He J, . The China National Diabetes and Metabolic Disorders Study Group Prevalence of Diabetes among Men and Women in China. N Engl J Med 2010, 362(12):1090-1101. 10.1056/NEJMoa0908292, 20335585, The China National Diabetes and Metabolic Disorders Study Group.
7. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C, . For the Conference Participants Definition of Metabolic Syndrome. Circulation 2004, 109(3):433-438. 10.1161/01.CIR.0000111245.75752.C6, 14744958, For the Conference Participants.
8. Mancia G, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R. Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis. Hypertension 2007, 49(1):40-47.
9. Galassi A, Reynolds K, He J. Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis. Am J Med 2006, 119(10):812-819. 10.1016/j.amjmed.2006.02.031, 17000207.
10. Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CDA, Bouter LM, Heine RJ. Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study. Circulation 2005, 112(5):666-673. 10.1161/CIRCULATIONAHA.104.516948, 16061755.
11. Zhang WW, Liu CY, Wang YJ, Xu ZQ, Chen Y, Zhou HD. Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol 2009, 256(9):1493-1499. 10.1007/s00415-009-5150-2, 19533205.
12. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults. Annals of Internal Medicine 2004, 140(3):167-174.
13. Vaidya D, Mathias RA, Kral BG, Yanek LR, Becker LC, Becker DM. Independent Metabolic Syndrome Variants Predict New Onset Coronary Artery Disease. Diabetes Care 2010,
14. Zhang Y, Hong J, Gu W, Gui M, Chen Y, Zhang Y, Chi Z, Wang W, Li X, Ning G. Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease. Endocrine 2009, 36(2):233-238. 10.1007/s12020-009-9214-y, 19618299.
15. Church TS, Thompson AM, Katzmarzyk PT, Sui X, Johannsen N, Earnest CP, Blair SN. Metabolic Syndrome and Diabetes, Alone and in Combination, as Predictors of Cardiovascular Disease Mortality Among Men. Diabetes Care 2009, 32(7):1289-1294. 10.2337/dc08-1871, 2699717, 19366967.
16. de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Biol 2006, 26(5):1086-1093. 10.1161/01.ATV.0000215951.36219.a4, 16514084.
17. Lee CC, Adler AI, Sandhu MS, Sharp SJ, Forouhi NG, Erqou S, Luben R, Bingham S, Khaw KT, Wareham NJ. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 2009, 52(6):1040-1047. 10.1007/s00125-009-1338-3, 19326095.
18. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of Endothelial Dysfunction and Risk of Type 2 Diabetes Mellitus. JAMA 2004, 291(16):1978-1986. 10.1001/jama.291.16.1978, 15113816.
19. Song Y, Manson JE, Tinker L, Rifai N, Cook NR, Hu FB, Hotamisligil GS, Ridker PM, Rodriguez BL, Margolis KL, Oberman A, Liu S. Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women. Diabetes 2007, 56(7):1898-1904. 10.2337/db07-0250, 1952236, 17389327.
20. Ingelsson E, Hulthe J, Lind L. Inflammatory markers in relation to insulin resistance and the metabolic syndrome. Eur J Clin Invest 2008, 38(7):502-509. 10.1111/j.1365-2362.2008.01962.x, 18489581.
21. Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004, 47(8):1403-1410.
22. Pischon T, Hu FB, Rexrode KM, Girman CJ, Manson JE, Rimm EB. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis 2008, 197(1):392-399. 10.1016/j.atherosclerosis.2007.06.022, 2375142, 17681508.
23. Jacobs M, van Greevenbroek MMJ, van der Kallen CJH, Ferreira I, Blaak E, Feskens EJM, Jansen EHJM, Schalkwijk C, Stehouwer CDA. The association between the metabolic syndrome and peripheral, but not coronary, artery disease is partly mediated by endothelial dysfunction: the CODAM study. Eur J Clin Invest 2011, 41(2):167-175. 10.1111/j.1365-2362.2010.02392.x, 21039444.
24. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004, 53(3):693-700. 10.2337/diabetes.53.3.693, 14988254.
25. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286(3):327-334. 10.1001/jama.286.3.327, 11466099.
26. Ye X, Franco OH, Yu Z, Li H, Hu FB, Liu H, Wang X, Tang H, Liu Y, Chen Y, Lin X. Associations of inflammatory factors with glycaemic status among middle-aged and older Chinese people. Clin Endocrinol 2009, 70(6):854-862.
27. Lin J, Zhang M, Song F, Qin J, Wang R, Yao P, Ying C, Hu FB, Liu L. Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population. Diabetes Metab Res Rev 2009, 25(3):219-223. 10.1002/dmrr.923, 19116941.
28. Hsu LA, Ko YL, Wu S, Teng MS, Chou HH, Chang CJ, Chang PY. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism 2009, 58(7):983-988. 10.1016/j.metabol.2009.02.021, 19394054.
29. Wen J, Liang Y, Wang F, Sun L, Guo Y, Duan X, Liu X, Tao Q, Wong TY, Lu X, Wang N. Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem 2009, 42(10-11):976-983. 10.1016/j.clinbiochem.2009.03.026, 19358836.
30. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007, 49(17):1798-1805. 10.1016/j.jacc.2007.01.065, 17466231.
31. Li H, Xu T, Tong W, Liu Y, Zhao L, Zhang Y. Comparison of Cardiovascular Risk Factors Between Prehypertension and Hypertension in a Mongolian Population, Inner Mongolia, China. Circ J 2008, 72(10):1666-1673. 10.1253/circj.CJ-08-0138, 18753701.
32. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem 1972, 18(6):499-502.
33. Emanuel RL, Cain JP, Williams GH. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973, 81:632-640.
34. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and Management of the Metabolic Syndrome. Circulation 2005, 112(17):2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
35. Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, Adab P, Lam TH, Cheng KK. c-Reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study. Atherosclerosis 2007, 194(2):483-489. 10.1016/j.atherosclerosis.2006.08.061, 17010351.
36. Leinonen E, Hurt-Camejo E, Wiklund O, Hultén LM, Hiukka A, Taskinen M. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003, 166(2):387-394. 10.1016/S0021-9150(02)00371-4, 12535753.
37. Goldberg RB. Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and Its Complications. J Clin Endocrinol Metab 2009, 94(9):3171-3182. 10.1210/jc.2008-2534, 19509100.